Provider
QP54-22 Update for New to Market Medical Drugs: betibeglogene autotemcel
Program effective Date: Jun 22, 2022
Documents & Forms Results
Displaying 461 - 470 of 3622 results
Provider
QP29-23 Blue Cross Preferred Genetic Laboratory Program
Program effective Date: Apr 12, 2023
Provider
QP30-23 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective May 1, 2023
Program effective Date: Apr 12, 2023
Provider
QP31-23 Commercial Pharmacy Benefit Exclusion for Fluticasone-Salmeterol
Program effective Date: Apr 12, 2023
Provider
QP32-23 Review and Update NPI Information
Program effective Date: Apr 12, 2023
Provider
QP33-23 Provider Survey: Training & Development Focusing on Equity in Health Care
Program effective Date: Apr 12, 2023
Provider
QP34-23 Update for New to Market Medical Drugs: Tofersen
Program effective Date: Apr 12, 2023
Provider
QP35-23 Notice of Correction to Ambulance Mileage Reimbursement
Program effective Date: Apr 12, 2023
Benefits & Coverage
BlueRide Parent or Guardian Ride Consent Form
Provider
P17-23 Inflation Reduction Act (IRA): Part B Rebatable Drugs and Part B Insulin Cap
Program effective Date: Apr 03, 2023